Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1993 Aug 15;9016:7533-7. doi: 10.1073/pnas.90.16.7533.
Show Gene links
Show Anatomy links
Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium.
Quinn TP
,
Peters KG
,
De Vries C
,
Ferrara N
,
Williams LT
.
???displayArticle.abstract???
Vascular endothelial growth factor (VEGF), also known as vascular permeability factor, induces endothelial proliferation in vitro and vascular permeability in vivo. The human transmembrane c-fms-like tyrosine kinase Flt-1 has recently been identified as a VEGF receptor. Flt-1 kinase has seven immunoglobulin-like extracellular domains and a kinase insert sequence, features shared by two other human gene-encoded proteins, kinase insert domain-containing receptor (KDR) and FLT-4. In this study we show that the mouse homologue of KDR, Flk-1, is a second functional VEGF receptor. Flk-1 binds VEGF with high affinity, undergoes autophosphorylation, and mediates VEGF-dependent Ca2+ efflux in Xenopus oocytes injected with Flk-1 mRNA. We also demonstrate by in situ hybridization that Flk-1 protein expression in the mouse embryo is restricted to the vascular endothelium and the umbilical cord stroma. VEGF and its receptors Flk-1/KDR and Flt-1 may play a role in vascular development and regulation of vascular permeability.
Clauss,
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.
1990, Pubmed
Clauss,
Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.
1990,
Pubmed
Conn,
Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor.
1990,
Pubmed
Criscuolo,
Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity.
1989,
Pubmed
Dumont,
tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors.
1992,
Pubmed
Field,
Purification of a RAS-responsive adenylyl cyclase complex from Saccharomyces cerevisiae by use of an epitope addition method.
1988,
Pubmed
Frohman,
Isolation of the mouse Hox-2.9 gene; analysis of embryonic expression suggests that positional information along the anterior-posterior axis is specified by mesoderm.
1990,
Pubmed
Galland,
Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene.
1992,
Pubmed
Houck,
The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.
1991,
Pubmed
Keck,
Vascular permeability factor, an endothelial cell mitogen related to PDGF.
1989,
Pubmed
Leung,
Vascular endothelial growth factor is a secreted angiogenic mitogen.
1989,
Pubmed
Maglione,
Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.
1991,
Pubmed
Matthews,
A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit.
1991,
Pubmed
Melton,
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.
1984,
Pubmed
Millauer,
High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.
1993,
Pubmed
Miller,
Improved retroviral vectors for gene transfer and expression.
1989,
Pubmed
Noden,
Embryonic origins and assembly of blood vessels.
1989,
Pubmed
Olander,
Specific binding of vascular permeability factor to endothelial cells.
1991,
Pubmed
Pajusola,
FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines.
1992,
Pubmed
Partanen,
A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains.
1992,
Pubmed
Pekala,
Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin.
1990,
Pubmed
Pepper,
Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells.
1991,
Pubmed
Plouët,
Characterization of the receptor to vasculotropin on bovine adrenal cortex-derived capillary endothelial cells.
1990,
Pubmed
Shibuya,
Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.
1990,
Pubmed
Terman,
Identification of a new endothelial cell growth factor receptor tyrosine kinase.
1991,
Pubmed
Terman,
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.
1992,
Pubmed
Tischer,
Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family.
1989,
Pubmed
Tischer,
The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing.
1991,
Pubmed
Vaisman,
Characterization of the receptors for vascular endothelial growth factor.
1990,
Pubmed
de Vries,
The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.
1992,
Pubmed
,
Xenbase
